Table. National laboratory capacity for Candida auris identification and testing and public health measures taken in response to C. auris, EU/EEA, January 2018–May 2019 (n = 29).
| Country | Notifiable | Mycology reference laboratory / laboratory with reference function | Antifungal susceptibility testing at reference laboratory | Provision of reference testing to hospital laboratories | Guidance for laboratory testing | Guidance for infection control | Prospective surveillance | Retrospective surveillance | Clinical alert in 2018 a | Laboratory alert in 2018 a |
|---|---|---|---|---|---|---|---|---|---|---|
| Austria | N | Y | Y | Y | Y | Y↑ | Y↑ | Y | Y | Y |
| Belgium | N | Y | Y | Y↑ | Y↑ | Y↑ | N | Y↑ | N | Y |
| Bulgaria | N | Y | Y | Y | N | N | N | N | N | Y |
| Croatia | N | Y | Y | Y↑ | N↓ | Y | Y↑ | N | Y | Y |
| Cyprus | N | N | N | N | N | N | N | N | N | N |
| Denmark | N | Y | Y | Yb | Y↑ | N | Y | Yb | N | Y |
| Estonia | N | N | N | N↓ | Y↑ | Nc | N | N | Y | N |
| Finland | Y | Y | Y | Y↑ | Y↑ | Y↑ | Y↑ | N | Y | Y |
| France | Y | Y | Y | Y | Y↑ | Y↑ | Y | Y | Y | Y |
| Germany | N | Y | Y | Y | Y | Y↑ | N↓ | N | N | Y |
| Greece | Y | Y | Y | Y | Y↑ | Y↑ | Y↑ | Y | Y | Y |
| Hungary | N | Y | Y | Y↑ | N | N | N | N | N | N |
| Iceland | N | Y | Y | Y | N | N | N↓ | N | N | N |
| Ireland | Y | N | N | Nd | N | N | Y | N | Y | N |
| Italy | Y | N | N | N | N | N | N | N | Y | Y |
| Latvia | N | N | N | N | N | N | N | N | N | N |
| Lithuania | N | Y | Y | N | N | N | N | N | N | N |
| Luxembourg | N | Y | N | Y↑ | N | N | N | N | N | N |
| Malta | N | Y | Y | Y↑ | N↓ | N | N | N | N | Y |
| Netherlands | N | Y | Y | N | Y↑ | N | N | Y | Y | Y |
| Norway | N | Y | Y | Y↑ | Y | N↓ | N | N | N | Y |
| Poland | N | N | N | N | N | N | N | N | N | N |
| Portugal | N | Y | Y | Y↑ | Y↑ | Y↑ | Y↑ | Y↑ | N | Y |
| Romania | N | N | N | N | N | N | N | N | N | N |
| Slovakia | N | Y↑ | Y↑ | N | N | N | N | N | N | N |
| Slovenia | N | Y | Y | Y | Y↑ | Y↑ | Y | N | N | Y |
| Spain | N | Y | Y | Y | N | Y↑ | N | N | Y | Y |
| Sweden | N | Y | Y | Y | N | N | N | N | Y | Y |
| United Kingdom | N | Y | Y | Y | Y | Y | Y | Y | N | N |
EEA: European Economic Area; EU: European Union; N: no; Y: yes.
a Only refers to 2018 and does not include alerts issued in previous years.
b Since 2010, all fungal bloodstream isolates in Denmark have been sent to the reference laboratory as part of the national fungaemia surveillance programme. From 2004 to 2009, only two thirds of the country was covered by this surveillance programme.
c Candida auris is addressed in general infection control guidelines.
d Advice for samples to be sent to the United Kingdom for reference testing.
Changes as compared with the previous survey that assessed the situation as at January 2018 are marked with ↑ (no to yes) or ↓ (yes to no).